Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
177
datasets available to search
ShareScore release 0.9.0
Dataset results
177 results for “nonalcoholic steatohepatitis”
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT04166773. IPD Sharing: YES. Countries: 10. Publications: 1.
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT02781584. IPD Sharing: NO. Countries: 2. Publications: 2.
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
ClinicalTrials.gov study NCT04048135. IPD Sharing: UNDECIDED. Countries: 2. Publications: 3.
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
ClinicalTrials.gov study NCT01066364. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT02787304. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
ClinicalTrials.gov study NCT01679197. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3
ClinicalTrials.gov study NCT02466516. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
ClinicalTrials.gov study NCT03053050. IPD Sharing: NO. Countries: 27. Publications: 6.
Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT04929483. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT04767529. IPD Sharing: NO. Countries: 2. Publications: 2.
Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis
ClinicalTrials.gov study NCT02856555. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT04618744. IPD Sharing: NO. Countries: 2. Publications: 6.
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
ClinicalTrials.gov study NCT00063232. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Treating Nonalcoholic Steatohepatitis With Pioglitazone
ClinicalTrials.gov study NCT00062764. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (
ClinicalTrials.gov study NCT03449446. IPD Sharing: NO. Countries: 6. Publications: 1.
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT03053063. IPD Sharing: YES. Countries: 22. Publications: 6.
Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT02854605. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
ClinicalTrials.gov study NCT03486899. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT04616014. IPD Sharing: NO. Countries: 1. Publications: 3.
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT03812029. IPD Sharing: Not stated. Countries: 5. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.